Molecular Studies Define the Primary Structure of α1-Antichymotrypsin (ACT) Protease Inhibitor in Alzheimer's Disease Brains
Open Access
- 1 January 1999
- journal article
- Published by Elsevier
- Vol. 274 (3) , 1821-1827
- https://doi.org/10.1074/jbc.274.3.1821
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Unique reactive site domains of neuroendocrine isoforms of alpha1‐antichymotrypsin from bovine adrenal medulla and pituitary revealed by molecular cloningFEBS Letters, 1995
- Purification and Characteristics of the Candidate Prohormone Processing Proteases PC2 and PC1/3 from Bovine Adrenal Medulla Chromaffin GranulesPublished by Elsevier ,1995
- Molecular cloning reveals isoforms of bovine alpha 1-antichymotrypsin.Proceedings of the National Academy of Sciences, 1994
- ?-1-Antichymotrypsin variant detected by PCR-single strand conformation polymorphism (PCR-SSCP) and direct sequencingHuman Genetics, 1992
- Crystal structure of cleaved human α1-antichymotrypsin at 2.7 å resolution and its comparison with other serpinsJournal of Molecular Biology, 1991
- α1-Antichymotrypsin is associated solely with amyloid deposits containing the β-protein. Amyloid and cell localization of α1-antichymotrypsinNeurobiology of Aging, 1990
- Immunochemical identification of the serine protease inhibitor α1-antichymotrypsin in the brain amyloid deposits of Alzheimer's diseaseCell, 1988
- Plasma protease inhibitors in mouse and man: divergence within the reactive centre regionsNature, 1984
- Sequence homology between human .alpha.1-antichymotrypsin, .alpha.1-antitrypsin, and antithrombin IIIBiochemistry, 1983
- HUMAN PLASMA PROTEINASE INHIBITORSAnnual Review of Biochemistry, 1983